Kanara
PrivateLast Round
Seed
Oct 15, 2023
Total Funding Raised
$2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kanara is a medical supplies company that provides pharmaceutical ingredients intended to improve the quality of life of patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kanara Comparables
Compare Kanara with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| In vitro Plant-tech AB | 88% | |
| Ayana Bio | 84% | |
| ACTV Biotechnology | 80% | |
Kanara Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 15, 2023 |
Key People
Founding team and executive leadership
Kanara Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 69% MoM, from 572 to 969.
- Jun 18, 2026
Monthly visitors increased 557% MoM, from 87 to 572.
Kanara Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kanara's valuation, stock price, and market status.